The article is from Zoa Bao and it discusses the promise the machine offers for an Alzheimers patient.

To read more on this article click here.

Researchers have found that focusing a magnetic field onto patients’ heads while they answer questions or solve puzzles can reduce the symptoms of dementia and improve their memories.

The treatment stimulates key regions of the brain involved in memory and learning, enhancing patients’ ability to make new memories.

The scientists behind the technique say it can allow Alzheimer’s patients to live far more independently than they otherwise would and extends the time they can spend with their families before suffering the devastating mental decline associated with the disease.

They are still conducting tests to see exactly how long the treatment can hold back the symptoms of the disease, which include loss of memory, confusion and changes in personality, but early trials suggest it can be effective for up to a year.

A trial of the technology is now being conducted with patients in Manchester.

To read more on this article click here.

Israel-based Neuronix, which has developed a non-invasive medical device to help to treat Alzheimer's disease, expects the system to be approved by the U.S. Food & Drug Administration in late 2014.

The device, which combines electromagnetic stimulation with computer-based cognitive training, is already approved for use in Europe, Israel and several Asian countries such as Singapore.

"You stimulate the brain on a biological level as well as on a cognitive level," Neuronix CEO Eyal Baror told Reuters, saying this double approach created longer-lasting benefits.

The device, which consists of a chair containing an electronic system and software in the back and a coil placed at the head, has been tested on mild to moderate Alzheimer's patients who suffer from dementia but are not totally dependent.

The system is in trials at Harvard Medical School/Beth Israel Deaconess Medical Centre. Patients are treated for one hour a day, five days a week over six weeks.

To read more on this article click here.

Neuronix Medical CEO Eyal Baror talks about his company's product and the expansion of trials in the U.S. He speaks on Bloomberg Television's "Bottom Line." (Source: Bloomberg)

To read more on this article click here.